Fuji, Japan

Masanori Ikeda

This inventor holds 21 USPTO granted patents and 6 EPO patents, primarily in Fluorinated Compounds. Top assignees: Asahi Kasei Kabushiki Kaisha, Asahi Kasei Kogyo Kabushiki Kaisha, Daikin Industries, Ltd.. Active years: 1978-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masanori Ikeda. Retrieved from https://idiyas.com/inventor/masanori-ikeda-u2rmiyoj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 76.2


Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 193(Granted Patents)


Location History:

  • Fuji, JP (1978 - 2010)
  • Shizuoka, JP (1990 - 2011)
  • Okayama, JP (2016)
  • Kagoshima, JP (2021)

Company Filing History:


Years Active: 1978-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-HCV Agent
Polymer Composition
Fluorinated Vinyl Ether
Hexafluoropropylene Oxide
Lubricant Oil Composition
Lewis Acid Catalyst
Refrigerant Composition
Polyphenylene Ether
Hybrid Polymeric Electrolyte
Superacid Ester Group
Anti-Hepatoma-Virus Agent
Quaternary Onium Salts
21 patents (USPTO):Explore Patents

Title: Masanori Ikeda: Innovator in Hepatoma and HCV Therapeutics

Introduction

Masanori Ikeda is a notable innovator based in Fuji, Japan, recognized for his significant contributions to the field of biopharmaceuticals. With an impressive portfolio of 21 patents, Ikeda has focused on developing therapeutic agents targeting hepatoma viruses and hepatitis C virus (HCV).

Latest Patents

Among his latest works, one of the key inventions is an anti-hepatoma virus agent. This innovative therapeutic agent provides a novel solution for treating hepatoma viruses, utilizing an active ingredient that is a compound outlined in a specific formula. Additionally, he has developed an anti-HCV agent that includes a peroxide derivative, demonstrating profound effectiveness in suppressing HCV-RNA replication. These latest patents reflect Ikeda's commitment to advancing medical therapies.

Career Highlights

Throughout his career, Ikeda has made significant strides in pharmaceutical research. He has been affiliated with Asahi Kasei Kogyo Kabushiki Kaisha and Asahi Kasei Corporation, where he contributed his expertise and innovative ideas towards impactful drug development.

Collaborations

Ikeda has collaborated with notable professionals in his field, including Atsushi Aoshima and Nobuyuki Uematsu. These partnerships have facilitated the sharing of knowledge and resources, further enhancing the potential of his research endeavors.

Conclusion

Masanori Ikeda's achievements in the realm of therapeutic agents mark him as a distinguished inventor. His dedication to combating hepatoma and HCV through innovative solutions continues to inspire advancements in biotechnology and pharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…